9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.

      Clinics in Chest Medicine
      AIDS-Related Opportunistic Infections, diagnosis, drug therapy, prevention & control, Anti-Retroviral Agents, therapeutic use, Antitubercular Agents, Drug Interactions, HIV Infections, complications, Humans, Immune Reconstitution Inflammatory Syndrome, etiology, Isoniazid, Latent Tuberculosis, Tuberculosis, Pulmonary, Virus Activation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tuberculosis (TB) is the leading cause of opportunistic infection and mortality among HIV-infected persons. Screening for symptoms of TB in people with HIV infection, use of isoniazid preventive therapy for those with latent TB infection, earlier diagnosis and treatment of active TB disease, and early initiation of antiretroviral therapy are essential for controlling the spread of TB. Treatment of HIV-related TB is complicated by overlapping drug toxicities and drug-drug interactions between antiretroviral therapy and anti-TB therapy and risk for development of immune reconstitution inflammatory disease. This review provides an overview of the prevention and treatment of TB in HIV-infected persons. Copyright © 2013 Elsevier Inc. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article